<- Go Home
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Market Cap
INR 47.4B
Volume
22.0K
Cash and Equivalents
N/A
EBITDA
INR 1.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 4.7B
Profit Margin
63.81%
52 Week High
INR 3.1K
52 Week Low
INR 1.7K
Dividend
0.84%
Price / Book Value
7.82
Price / Earnings
39.59
Price / Tangible Book Value
7.93
Enterprise Value
INR 44.8B
Enterprise Value / EBITDA
29.06
Operating Income
INR 1.3B
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
INR 2.7B
Debt
INR 200.0M
Equity
INR 6.1B
Revenue
INR 7.3B
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A